LEICA INC. – Trademark Portfolio

Entity Type: 03

LEICA INC. holds 22 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 18 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include LEICA, DUO-CHEK, REICHERT, BRAKE-CHEK, and PROJECT-O-CHART. The owner is based in DEPEW, NY.

3362 WALDEN AVENUE

DEPEW, NY 14043

22 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

LEICA INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (18 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

10
Medical Apparatus (6 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does LEICA INC. have?

LEICA INC. has 22 U.S. trademarks filed with the USPTO. Of these, 6 registered, 5 abandoned, 11 cancelled.

What trademark classes does LEICA INC. file in?

LEICA INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are LEICA INC.'s most well-known trademarks?

LEICA INC.'s registered trademark portfolio includes well-known marks such as LEICA, DUO-CHEK, REICHERT, BRAKE-CHEK, and PROJECT-O-CHART. These are among 6 currently registered trademarks in the portfolio.

What is LEICA INC.'s trademark registration success rate?

LEICA INC. has a 27% trademark registration rate, with 6 out of 22 resolved applications resulting in successful registration. Currently, 0 applications are pending review.